Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward M Messing

Showing results (151-160 of 199) with videos related to

Pageof 20
Sort By:
European Urology Focus|February 27, 2019
Prognostic DNA Methylation Biomarkers in High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective ValidationPratik M S Gurung, Abigail R Barnett, Jayne S Wilson, et al.
Bladder Cancer (Amsterdam, Netherlands)|October 8, 2021
A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder CancerRyan M Reyes, Emily Rios, Shane Barney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trialEdward M Messing, Judith Manola, George Wilding, et al.
BMC Urology|August 18, 2012
Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expressionTimothy K Byler, Dean Leocadio, Oleg Shapiro, et al.
Cancer|May 21, 2009
Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumorsRalph Madeb, Dragan Golijanin, Katia Noyes, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
Androgen receptor is a tumor suppressor and proliferator in prostate cancerYuanjie Niu, Saleh Altuwaijri, Kuo-Pao Lai, et al.
Oncogene|April 11, 2025
Protein disulfide isomerase-enriched extracellular vesicles from bladder cancer cells support tumor survival and malignant transformation in the bladderChia-Hao Wu, Kit L Yuen, Ryan D Molony, et al.
The EMBO Journal|August 13, 2003
Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau proteinXi Na, Hai Ou Duan, Edward M Messing, et al.
BJU International|January 7, 2012
Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladderHiroshi Miyamoto, Jorge L Yao, Alcides Chaux, et al.
Oncotarget|April 20, 2016
Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancerZhiqun Shang, Yanjun Li, Iawen Hsu, et al.
Pageof 20

Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
European Urology Focus|February 27, 2019
Prognostic DNA Methylation Biomarkers in High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective ValidationPratik M S Gurung, Abigail R Barnett, Jayne S Wilson, et al.
Bladder Cancer (Amsterdam, Netherlands)|October 8, 2021
A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder CancerRyan M Reyes, Emily Rios, Shane Barney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trialEdward M Messing, Judith Manola, George Wilding, et al.
BMC Urology|August 18, 2012
Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expressionTimothy K Byler, Dean Leocadio, Oleg Shapiro, et al.
Cancer|May 21, 2009
Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumorsRalph Madeb, Dragan Golijanin, Katia Noyes, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
Androgen receptor is a tumor suppressor and proliferator in prostate cancerYuanjie Niu, Saleh Altuwaijri, Kuo-Pao Lai, et al.
Oncogene|April 11, 2025
Protein disulfide isomerase-enriched extracellular vesicles from bladder cancer cells support tumor survival and malignant transformation in the bladderChia-Hao Wu, Kit L Yuen, Ryan D Molony, et al.
The EMBO Journal|August 13, 2003
Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau proteinXi Na, Hai Ou Duan, Edward M Messing, et al.
BJU International|January 7, 2012
Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladderHiroshi Miyamoto, Jorge L Yao, Alcides Chaux, et al.
Oncotarget|April 20, 2016
Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancerZhiqun Shang, Yanjun Li, Iawen Hsu, et al.
Pageof 20